Research momentum is pushing STAT3 into the limelight as both a mechanistic hub and a possible drug target. But prior “master regulator” narratives in neurodegeneration have not reliably survived clinical translation.
STAT3 in Alzheimer’s: Master Switch or Mixed Messenger?
Is STAT3 a credible and actionable therapeutic target in Alzheimer’s disease, or just a marker of chronic neuroinflammation?